O	O	O	0	3	The	The	B-NP	DT	O	13	NMOD	O
T1	B-Protein	B-Protein	4	15	interleukin	interleukin	I-NP	NN	B-protein	13	NMOD	B-protein
T1	I-Protein	I-Protein	15	16	-	-	O	HYPH	O	13	NMOD	O
T1	I-Protein	I-Protein	16	17	8	8	B-NP	CD	O	13	NMOD	O
O	O	O	18	20	AP	AP	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	20	21	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
O	O	O	21	22	1	1	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	O	23	26	and	and	O	CC	O	13	NMOD	O
O	O	O	27	32	kappa	kappa	B-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	O	33	34	B	B	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	34	35	-	-	B-NP	HYPH	I-DNA	13	NMOD	I-DNA
O	O	O	35	39	like	like	I-NP	JJ	I-DNA	13	NMOD	I-DNA
T18	B-Entity	B-Entity	40	45	sites	site	I-NP	NNS	I-DNA	14	SUB	I-DNA
O	O	O	46	49	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	50	57	genetic	genetic	B-NP	JJ	O	17	NMOD	O
O	O	O	58	61	end	end	I-NP	NN	O	17	NMOD	O
O	O	O	62	69	targets	target	I-NP	NNS	O	14	PRD	O
O	O	O	70	72	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	73	78	FK506	FK506	B-NP	NN	O	22	NMOD	O
O	O	O	78	79	-	-	B-NP	HYPH	O	22	NMOD	O
O	O	O	79	88	sensitive	sensitive	I-NP	JJ	O	22	NMOD	O
O	O	O	89	96	pathway	pathway	I-NP	NN	O	18	PMOD	O
O	O	O	97	108	accompanied	accompany	B-VP	VBN	O	22	NMOD	O
O	O	O	109	111	by	by	B-PP	IN	O	23	VMOD	O
O	O	O	112	119	calcium	calcium	B-NP	NN	O	26	NMOD	O
O	O	O	120	132	mobilization	mobilization	I-NP	NN	O	24	PMOD	O
O	O	O	132	133	.	.	O	.	O	14	P	O

O	O	O	135	140	FK506	FK506	B-NP	NN	O	4	NMOD	O
O	O	O	140	141	,	,	O	,	O	4	P	O
O	O	O	142	144	an	an	B-NP	DT	O	4	NMOD	O
O	O	O	145	162	immunosuppressant	immunosuppressant	I-NP	NN	O	6	SUB	O
O	O	O	162	163	,	,	O	,	O	4	P	O
O	O	O	164	172	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	O	173	176	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	177	187	production	production	I-NP	NN	O	6	OBJ	O
O	O	O	188	190	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	191	198	several	several	B-NP	JJ	O	9	PMOD	O
O	O	O	199	208	cytokines	cytokine	I-NP	NNS	B-protein	10	NMOD	B-protein
O	O	O	209	211	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	212	213	T	T	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	O	214	225	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	225	226	.	.	O	.	O	6	P	O

O	O	O	227	229	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	230	238	observed	observe	B-VP	VBD	O	0	ROOT	O
O	O	O	239	243	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	244	249	FK506	FK506	B-NP	NN	O	5	SUB	O
O	O	O	250	260	suppressed	suppress	B-VP	VBD	O	3	SBAR	O
O	O	O	261	264	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	265	278	transcription	transcription	I-NP	NN	O	5	OBJ	O
O	O	O	279	281	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	282	283	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	284	295	chemotactic	chemotactic	I-NP	JJ	B-protein	11	NMOD	B-protein
O	O	O	296	304	cytokine	cytokine	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	304	305	,	,	O	,	O	14	P	O
T2	B-Protein	B-Protein	306	317	interleukin	interleukin	B-NP	NN	B-protein	14	NMOD	B-protein
T2	I-Protein	I-Protein	317	318	-	-	O	HYPH	O	15	P	O
T2	I-Protein	I-Protein	318	319	8	8	B-NP	CD	O	8	PMOD	O
O	O	O	320	321	(	(	O	(	O	20	DEP	O
T3	B-Protein	B-Protein	321	323	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T3	I-Protein	I-Protein	323	324	-	-	B-NP	HYPH	I-protein	20	DEP	I-protein
T3	I-Protein	I-Protein	324	325	8	8	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	325	326	)	)	O	)	O	15	NMOD	O
O	O	O	327	329	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	330	331	a	a	B-NP	DT	O	26	NMOD	O
O	O	O	332	337	human	human	I-NP	JJ	B-cell_line	26	NMOD	B-cell_line
O	O	O	338	339	T	T	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	340	344	cell	cell	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	345	349	line	line	I-NP	NN	I-cell_line	29	NMOD	I-cell_line
O	O	O	349	350	,	,	O	,	O	29	P	O
O	O	O	351	357	Jurkat	Jurkat	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	O	358	363	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	363	364	,	,	O	,	O	15	P	O
O	O	O	365	374	activated	activate	B-VP	VBN	O	15	NMOD	O
O	O	O	375	377	by	by	B-PP	IN	O	31	VMOD	O
O	O	O	378	385	phorbol	phorbol	B-NP	NN	O	39	NMOD	O
O	O	O	386	388	12	12	I-NP	CD	O	33	NMOD	O
O	O	O	388	389	-	-	O	HYPH	O	39	NMOD	O
O	O	O	389	398	myristate	myristate	B-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	399	401	13	13	I-NP	CD	I-protein	36	NMOD	I-protein
O	O	O	401	402	-	-	O	HYPH	O	36	P	O
O	O	O	402	409	acetate	acetate	B-NP	NN	O	44	NMOD	O
O	O	O	410	411	(	(	O	(	O	42	DEP	O
O	O	O	411	414	PMA	PMA	B-NP	NN	O	42	DEP	O
O	O	O	414	415	)	)	O	)	O	39	NMOD	O
O	O	O	416	419	and	and	O	CC	O	44	NMOD	O
O	O	O	420	427	calcium	calcium	B-NP	NN	O	49	NMOD	O
O	O	O	428	429	(	(	O	(	O	49	NMOD	O
O	O	O	429	432	Ca2	Ca2	B-NP	NN	B-protein	49	NMOD	B-protein
O	O	O	432	433	+	+	O	SYM	O	49	NMOD	O
O	O	O	433	434	)	)	O	)	O	49	NMOD	O
O	O	O	435	444	ionophore	ionophore	B-NP	NN	O	32	PMOD	O
O	O	O	445	446	(	(	O	(	O	52	DEP	O
O	O	O	446	455	ionomycin	ionomycin	B-NP	NN	O	52	DEP	O
O	O	O	455	456	)	)	O	)	O	49	NMOD	O
O	O	O	456	457	.	.	O	.	O	2	P	O

O	O	O	458	460	By	By	B-PP	IN	O	0	ROOT	O
O	O	O	461	468	deleted	delete	B-VP	VBN	O	22	NMOD	O
O	O	O	469	472	and	and	O	CC	O	22	NMOD	O
O	O	O	473	480	mutated	mutate	B-VP	VBN	O	5	NMOD	O
O	O	O	481	489	analysis	analysis	B-NP	NN	O	22	NMOD	O
O	O	O	490	492	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	493	496	the	the	B-NP	DT	O	11	NMOD	O
T4	B-Protein	B-Protein	497	499	IL	IL	I-NP	NN	B-DNA	11	NMOD	B-DNA
T4	I-Protein	I-Protein	499	500	-	-	O	HYPH	I-DNA	11	NMOD	I-DNA
T4	I-Protein	I-Protein	500	501	8	8	B-NP	CD	I-DNA	11	NMOD	I-DNA
T19	B-Entity	B-Entity	502	511	promoters	promoter	I-NP	NNS	I-DNA	6	PMOD	I-DNA
O	O	O	511	512	,	,	O	,	O	22	P	O
O	O	O	513	516	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	517	519	AP	AP	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	519	520	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	O	520	521	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	522	525	and	and	O	CC	O	22	NMOD	O
O	O	O	526	531	kappa	kappa	B-NP	NN	B-DNA	19	NMOD	B-DNA
O	O	O	532	533	B	B	I-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	O	533	534	-	-	B-VP	HYPH	I-DNA	22	NMOD	I-DNA
O	O	O	534	538	like	like	B-NP	JJ	I-DNA	22	NMOD	I-DNA
T20	B-Entity	B-Entity	539	544	sites	site	I-NP	NNS	I-DNA	23	SUB	I-DNA
O	O	O	545	549	were	be	B-VP	VBD	O	1	SBAR	O
O	O	O	550	560	identified	identify	I-VP	VBN	O	23	VC	O
O	O	O	561	563	as	as	B-PP	IN	O	24	VMOD	O
O	O	O	564	567	the	the	B-NP	DT	O	28	NMOD	O
T21	B-Entity	B-Entity	568	578	responsive	responsive	I-NP	JJ	B-DNA	28	NMOD	B-DNA
T21	I-Entity	I-Entity	579	587	elements	element	I-NP	NNS	I-DNA	25	PMOD	I-DNA
O	O	O	588	591	for	for	B-PP	IN	O	28	NMOD	O
O	O	O	592	595	PMA	PMA	B-NP	NN	O	32	NMOD	O
O	O	O	596	599	and	and	I-NP	CC	O	32	NMOD	O
O	O	O	600	609	ionomycin	ionomycin	I-NP	NN	O	29	PMOD	O
O	O	O	609	610	.	.	O	.	O	1	P	O

O	O	O	611	616	FK506	FK506	B-NP	NN	O	2	SUB	O
O	O	O	617	627	suppressed	suppress	B-VP	VBD	O	0	ROOT	O
O	O	O	628	631	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	632	646	transcriptions	transcription	I-NP	NNS	O	2	OBJ	O
O	O	O	647	654	through	through	B-PP	IN	O	4	NMOD	O
O	O	O	655	658	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	659	661	AP	AP	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	661	662	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	O	662	663	1	1	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	664	666	or	or	O	CC	O	15	NMOD	O
O	O	O	667	672	kappa	kappa	B-NP	NN	B-DNA	12	NMOD	B-DNA
O	O	O	673	674	B	B	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	O	674	675	-	-	B-NP	HYPH	I-DNA	15	NMOD	I-DNA
O	O	O	675	679	like	like	I-NP	JJ	I-DNA	15	NMOD	I-DNA
T22	B-Entity	B-Entity	680	685	sites	site	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	686	693	induced	induce	B-VP	VBN	O	15	NMOD	O
O	O	O	694	696	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	697	700	PMA	PMA	B-NP	NN	O	20	NMOD	O
O	O	O	701	705	plus	plus	O	CC	O	20	NMOD	O
O	O	O	706	708	Ca	Ca	B-NP	NN	O	17	PMOD	O
O	O	O	708	709	(	(	O	(	O	24	DEP	O
O	O	O	709	710	2	2	B-NP	CD	O	23	NMOD	O
O	O	O	710	711	+	+	O	SYM	O	24	DEP	O
O	O	O	711	712	)	)	O	)	O	20	NMOD	O
O	O	O	712	713	-	-	O	HYPH	O	20	P	O
O	O	O	713	723	mobilizing	mobilize	B-NP	VBG	O	27	NMOD	O
O	O	O	724	730	agents	agent	I-NP	NNS	O	20	NMOD	O
O	O	O	730	731	,	,	O	,	O	17	P	O
O	O	O	732	735	but	but	B-CONJP	CC	O	17	PMOD	O
O	O	O	736	739	not	not	I-CONJP	RB	O	29	DEP	O
O	O	O	740	745	those	those	B-NP	DT	O	41	NMOD	O
O	O	O	746	753	induced	induce	B-VP	VBN	O	31	NMOD	O
O	O	O	754	756	by	by	B-PP	IN	O	32	VMOD	O
O	O	O	757	759	Ca	Ca	B-NP	NN	O	33	PMOD	O
O	O	O	759	760	(	(	O	(	O	38	DEP	O
O	O	O	760	761	2	2	B-NP	CD	O	37	NMOD	O
O	O	O	761	762	+	+	O	SYM	O	38	DEP	O
O	O	O	762	763	)	)	O	)	O	31	NMOD	O
O	O	O	763	764	-	-	B-NP	HYPH	O	41	NMOD	O
O	O	O	764	775	independent	independent	I-NP	JJ	O	41	NMOD	O
O	O	O	776	783	stimuli	stimulus	I-NP	NNS	O	17	PMOD	O
O	O	O	783	784	.	.	O	.	O	2	P	O

O	O	O	785	787	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	788	791	gel	gel	B-NP	NN	O	4	NMOD	O
O	O	O	792	803	retardation	retardation	I-NP	NN	O	4	NMOD	O
O	O	O	804	812	analysis	analysis	I-NP	NN	O	1	PMOD	O
O	O	O	812	813	,	,	O	,	O	7	P	O
O	O	O	814	819	FK506	FK506	B-NP	NN	O	7	SUB	O
O	O	O	820	823	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	824	830	little	little	B-NP	JJ	O	9	NMOD	O
O	O	O	831	837	effect	effect	I-NP	NN	O	7	OBJ	O
O	O	O	838	840	on	on	B-PP	IN	O	7	VMOD	O
O	O	O	841	844	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	845	852	binding	binding	I-NP	NN	O	10	PMOD	O
O	O	O	853	855	to	to	B-PP	TO	O	12	NMOD	O
O	O	O	856	859	the	the	B-NP	DT	O	18	NMOD	O
T23	B-Entity	B-Entity	860	862	AP	AP	I-NP	NN	B-DNA	18	NMOD	B-DNA
T23	I-Entity	I-Entity	862	863	-	-	B-NP	HYPH	I-DNA	18	NMOD	I-DNA
T23	I-Entity	I-Entity	863	864	1	1	I-NP	CD	I-DNA	18	NMOD	I-DNA
T23	I-Entity	I-Entity	865	869	site	site	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	870	872	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	873	876	PMA	PMA	B-NP	NN	O	26	NMOD	O
O	O	O	876	877	/	/	B-NP	SYM	O	26	P	O
O	O	O	877	886	ionomycin	ionomycin	I-NP	NN	O	26	NMOD	O
O	O	O	886	887	-	-	O	HYPH	O	22	P	O
O	O	O	887	894	induced	induce	B-NP	VBN	O	26	NMOD	O
O	O	O	895	902	nuclear	nuclear	I-NP	JJ	B-protein	26	NMOD	B-protein
O	O	O	903	910	factors	factor	I-NP	NNS	I-protein	19	PMOD	I-protein
O	O	O	910	911	,	,	O	,	O	26	P	O
O	O	O	912	917	which	which	B-NP	WDT	O	26	NMOD	O
O	O	O	918	922	were	be	B-VP	VBD	O	28	SBAR	O
O	O	O	923	933	recognized	recognize	I-VP	VBN	O	29	VC	O
O	O	O	934	938	with	with	B-PP	IN	O	30	VMOD	O
O	O	O	939	943	anti	anti	B-NP	AFX	O	39	NMOD	O
O	O	O	943	944	-	-	I-NP	HYPH	O	39	NMOD	O
T5	B-Protein	B-Protein	944	948	JunD	JunD	I-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	949	951	or	or	I-NP	CC	O	39	NMOD	O
T6	B-Protein	B-Protein	952	953	c	c	I-NP	NN	B-protein	39	NMOD	B-protein
T6	I-Protein	I-Protein	953	954	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T6	I-Protein	I-Protein	954	957	Fos	Fos	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	O	958	966	antibody	antibody	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	O	966	967	.	.	O	.	O	7	P	O

O	O	O	968	970	In	In	B-PP	IN	O	13	VMOD	O
O	O	O	971	979	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	979	980	,	,	O	,	O	13	P	O
O	O	O	981	986	FK506	FK506	B-NP	NN	O	6	NMOD	O
O	O	O	987	989	or	or	O	CC	O	6	NMOD	O
O	O	O	990	994	EGTA	EGTA	B-NP	NN	O	13	SUB	O
O	O	O	995	996	(	(	O	(	O	11	DEP	O
O	O	O	996	999	Ca2	Ca2	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	999	1000	+	+	B-NP	SYM	O	10	NMOD	O
O	O	O	1001	1009	chelator	chelator	I-NP	NN	O	11	DEP	O
O	O	O	1009	1010	)	)	O	)	O	6	NMOD	O
O	O	O	1011	1020	similarly	similarly	B-VP	RB	O	13	VMOD	O
O	O	O	1021	1029	affected	affect	I-VP	VBD	O	0	ROOT	O
O	O	O	1030	1033	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	1034	1043	formation	formation	I-NP	NN	O	13	OBJ	O
O	O	O	1044	1046	of	of	B-PP	IN	O	15	NMOD	O
T24	B-Entity	B-Entity	1047	1052	kappa	kappa	B-NP	NN	B-protein	23	NMOD	B-protein
T24	I-Entity	I-Entity	1053	1054	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	1054	1055	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	1055	1059	like	like	I-NP	JJ	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	1060	1064	site	site	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	1065	1072	binding	binding	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	1073	1082	complexes	complex	I-NP	NNS	I-protein	16	PMOD	I-protein
O	O	O	1082	1083	,	,	O	,	O	23	P	O
O	O	O	1084	1089	which	which	B-NP	WDT	O	23	NMOD	O
O	O	O	1090	1094	were	be	B-VP	VBD	O	25	SBAR	O
O	O	O	1095	1098	not	not	I-VP	RB	O	26	VMOD	O
O	O	O	1099	1109	recognized	recognize	I-VP	VBN	O	26	VC	O
O	O	O	1110	1112	by	by	B-PP	IN	O	28	VMOD	O
O	O	O	1113	1116	any	any	B-NP	DT	O	31	NMOD	O
O	O	O	1117	1127	antibodies	antibody	I-NP	NNS	B-protein	29	PMOD	B-protein
O	O	O	1128	1135	against	against	B-PP	IN	O	31	NMOD	O
O	O	O	1136	1139	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	1140	1145	human	human	I-NP	JJ	B-protein	37	NMOD	B-protein
O	O	O	1146	1149	Rel	Rel	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	1150	1156	family	family	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	1157	1165	proteins	protein	I-NP	NNS	I-protein	32	PMOD	I-protein
O	O	O	1166	1167	(	(	O	(	O	49	DEP	O
T7	B-Protein	B-Protein	1167	1168	c	c	O	NN	B-protein	48	NMOD	B-protein
T7	I-Protein	I-Protein	1168	1169	-	-	O	HYPH	I-protein	48	P	I-protein
T7	I-Protein	I-Protein	1169	1172	Rel	Rel	B-NP	NN	I-protein	48	NMOD	I-protein
O	O	O	1172	1173	,	,	O	,	O	48	P	O
T8	B-Protein	B-Protein	1174	1177	p65	p65	B-NP	NN	B-protein	48	NMOD	B-protein
O	O	O	1177	1178	,	,	O	,	O	48	P	O
T9	B-Protein	B-Protein	1179	1182	p50	p50	B-NP	NN	B-protein	48	NMOD	B-protein
O	O	O	1182	1183	,	,	O	,	O	48	P	O
O	O	O	1184	1187	and	and	O	CC	O	48	NMOD	O
T10	B-Protein	B-Protein	1188	1191	p49	p49	B-NP	NN	B-protein	49	DEP	B-protein
O	O	O	1191	1192	)	)	O	)	O	37	NMOD	O
O	O	O	1192	1193	.	.	O	.	O	13	P	O

O	O	O	1194	1205	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	O	1205	1206	,	,	O	,	O	4	P	O
O	O	O	1207	1209	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	1210	1219	confirmed	confirm	B-VP	VBD	O	0	ROOT	O
O	O	O	1220	1223	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1224	1232	previous	previous	I-NP	JJ	O	7	NMOD	O
O	O	O	1233	1239	report	report	I-NP	NN	O	4	OBJ	O
O	O	O	1240	1244	that	that	B-SBAR	IN	O	7	NMOD	O
O	O	O	1245	1250	FK506	FK506	B-NP	NN	O	10	SUB	O
O	O	O	1251	1261	suppressed	suppress	B-VP	VBD	O	8	SBAR	O
O	O	O	1262	1265	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1266	1269	PMA	PMA	I-NP	NN	O	17	NMOD	O
O	O	O	1269	1270	/	/	B-NP	SYM	O	17	NMOD	O
O	O	O	1270	1279	ionomycin	ionomycin	I-NP	NN	O	17	NMOD	O
O	O	O	1279	1280	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	1280	1287	induced	induce	I-NP	VBN	O	17	NMOD	O
O	O	O	1288	1298	activation	activation	I-NP	NN	O	10	OBJ	O
O	O	O	1299	1306	through	through	B-PP	IN	O	10	VMOD	O
O	O	O	1307	1316	authentic	authentic	B-NP	JJ	O	22	NMOD	O
T25	B-Entity	B-Entity	1317	1322	kappa	kappa	I-NP	NN	B-DNA	22	NMOD	B-DNA
T25	I-Entity	I-Entity	1323	1324	B	B	I-NP	NN	I-DNA	22	NMOD	I-DNA
T25	I-Entity	I-Entity	1325	1329	site	site	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	O	1330	1332	of	of	B-PP	IN	O	22	NMOD	O
T26	B-Entity	B-Entity	1333	1347	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	28	NMOD	B-DNA
T26	I-Entity	I-Entity	1348	1349	(	(	O	(	I-DNA	28	NMOD	I-DNA
T26	I-Entity	I-Entity	1349	1351	Ig	Ig	B-NP	NN	I-DNA	28	NMOD	I-DNA
T26	I-Entity	I-Entity	1351	1352	)	)	O	)	I-DNA	28	NMOD	I-DNA
T26	I-Entity	I-Entity	1353	1357	gene	gene	B-NP	NN	I-DNA	23	PMOD	I-DNA
O	O	O	1357	1358	,	,	O	,	O	22	P	O
O	O	O	1359	1361	to	to	B-PP	TO	O	22	NMOD	O
O	O	O	1362	1367	which	which	B-NP	WDT	O	30	PMOD	O
T27	B-Entity	B-Entity	1368	1370	NF	NF	I-NP	NN	B-protein	36	NMOD	B-protein
T27	I-Entity	I-Entity	1370	1371	-	-	I-NP	HYPH	I-protein	36	NMOD	I-protein
T27	I-Entity	I-Entity	1371	1376	kappa	kappa	I-NP	NN	I-protein	36	NMOD	I-protein
T27	I-Entity	I-Entity	1377	1378	B	B	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	O	1379	1386	binding	binding	I-NP	NN	O	30	PMOD	O
O	O	O	1387	1390	was	be	B-VP	VBD	O	4	VMOD	O
O	O	O	1391	1395	also	also	I-VP	RB	O	37	VMOD	O
O	O	O	1396	1405	decreased	decrease	I-VP	VBN	O	37	VC	O
O	O	O	1406	1408	by	by	B-PP	IN	O	39	VMOD	O
O	O	O	1409	1414	FK506	FK506	B-NP	NN	O	40	PMOD	O
O	O	O	1414	1415	,	,	O	,	O	4	P	O
O	O	O	1416	1426	indicating	indicate	B-VP	VBG	O	4	VMOD	O
O	O	O	1427	1431	that	that	B-SBAR	IN	O	43	VMOD	O
O	O	O	1432	1436	both	both	O	CC	O	58	NMOD	O
T11	B-Protein	B-Protein	1437	1439	IL	IL	B-NP	NN	B-DNA	53	NMOD	B-DNA
T11	I-Protein	I-Protein	1439	1440	-	-	O	HYPH	I-DNA	53	NMOD	I-DNA
T11	I-Protein	I-Protein	1440	1441	8	8	B-NP	CD	I-DNA	53	NMOD	I-DNA
T28	B-Entity	B-Entity	1442	1447	kappa	kappa	I-NP	NN	I-DNA	53	NMOD	I-DNA
T28	I-Entity	I-Entity	1448	1449	B	B	I-NP	NN	I-DNA	53	NMOD	I-DNA
T28	I-Entity	I-Entity	1449	1450	-	-	B-NP	HYPH	I-DNA	53	NMOD	I-DNA
T28	I-Entity	I-Entity	1450	1454	like	like	I-NP	JJ	I-DNA	53	NMOD	I-DNA
T28	I-Entity	I-Entity	1455	1459	site	site	I-NP	NN	I-DNA	58	NMOD	I-DNA
O	O	O	1460	1463	and	and	I-NP	CC	O	58	NMOD	O
T12	B-Protein	B-Protein	1464	1466	Ig	Ig	I-NP	NN	O	58	NMOD	O
T12	I-Protein	I-Protein	1467	1472	kappa	kappa	I-NP	NN	B-DNA	58	NMOD	B-DNA
T12	I-Protein	I-Protein	1473	1474	B	B	I-NP	NN	I-DNA	58	NMOD	I-DNA
T29	B-Entity	B-Entity	1475	1479	site	site	I-NP	NN	I-DNA	59	SUB	I-DNA
O	O	O	1480	1483	are	be	B-VP	VBP	O	44	SBAR	O
O	O	O	1484	1489	FK506	FK506	B-NP	NN	O	62	AMOD	O
O	O	O	1489	1490	-	-	B-ADJP	HYPH	O	62	AMOD	O
O	O	O	1490	1499	sensitive	sensitive	I-ADJP	JJ	O	59	PRD	O
O	O	O	1500	1502	in	in	B-PP	IN	O	62	AMOD	O
O	O	O	1503	1508	spite	spite	B-NP	NN	O	63	PMOD	O
O	O	O	1509	1511	of	of	B-PP	IN	O	64	NMOD	O
O	O	O	1512	1515	the	the	B-NP	DT	O	67	NMOD	O
O	O	O	1516	1526	difference	difference	I-NP	NN	O	65	PMOD	O
O	O	O	1527	1529	of	of	B-PP	IN	O	67	NMOD	O
O	O	O	1530	1537	binding	bind	B-NP	VBG	B-protein	70	NMOD	B-protein
O	O	O	1538	1545	factors	factor	I-NP	NNS	I-protein	68	PMOD	I-protein
O	O	O	1545	1546	.	.	O	.	O	4	P	O

O	O	O	1547	1550	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1551	1558	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1559	1567	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1568	1572	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1573	1576	not	not	B-CONJP	RB	O	40	NMOD	O
O	O	O	1577	1581	only	only	I-CONJP	RB	O	5	DEP	O
O	O	O	1582	1585	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1586	1594	reported	report	I-NP	VBN	O	19	NMOD	O
T13	B-Protein	B-Protein	1595	1597	IL	IL	I-NP	NN	B-protein	19	NMOD	B-protein
T13	I-Protein	I-Protein	1597	1598	-	-	O	HYPH	I-protein	19	NMOD	I-protein
T13	I-Protein	I-Protein	1598	1599	2	2	B-NP	CD	I-protein	14	NMOD	I-protein
T14	I-Protein	I-Protein	1600	1602	NF	NF	I-NP	NN	B-protein	14	NMOD	B-protein
T14	I-Protein	I-Protein	1602	1603	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T14	I-Protein	I-Protein	1603	1605	AT	AT	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	1606	1609	and	and	I-NP	CC	O	16	NMOD	O
T15	B-Protein	B-Protein	1610	1614	NFIL	NFIL	I-NP	NN	B-protein	19	NMOD	B-protein
T15	I-Protein	I-Protein	1614	1615	-	-	B-NP	HYPH	O	19	NMOD	O
T15	I-Protein	I-Protein	1615	1617	2A	2A	I-NP	NN	B-DNA	19	NMOD	B-DNA
T30	B-Entity	B-Entity	1618	1623	sites	site	I-NP	NNS	I-DNA	24	NMOD	I-DNA
O	O	O	1624	1627	and	and	O	CC	O	24	NMOD	O
T16	B-Protein	B-Protein	1628	1630	Ig	Ig	B-NP	NN	O	24	NMOD	O
T16	I-Protein	I-Protein	1631	1636	kappa	kappa	I-NP	NN	B-DNA	24	NMOD	B-DNA
T16	I-Protein	I-Protein	1637	1638	B	B	I-NP	NN	I-DNA	24	NMOD	I-DNA
T31	B-Entity	B-Entity	1639	1643	site	site	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	1643	1644	,	,	O	,	O	40	P	O
O	O	O	1645	1648	but	but	B-CONJP	CC	O	40	NMOD	O
O	O	O	1649	1653	also	also	I-CONJP	RB	O	26	DEP	O
O	O	O	1654	1657	the	the	B-NP	DT	O	40	NMOD	O
T17	B-Protein	B-Protein	1658	1660	IL	IL	I-NP	NN	B-protein	40	NMOD	B-protein
T17	I-Protein	I-Protein	1660	1661	-	-	O	HYPH	I-protein	40	NMOD	I-protein
T17	I-Protein	I-Protein	1661	1662	8	8	B-NP	CD	I-protein	40	NMOD	I-protein
O	O	O	1663	1665	AP	AP	I-NP	NN	B-protein	40	NMOD	B-protein
O	O	O	1665	1666	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
O	O	O	1666	1667	1	1	I-NP	CD	I-protein	33	NMOD	I-protein
O	O	O	1668	1671	and	and	O	CC	O	40	NMOD	O
O	O	O	1672	1677	kappa	kappa	B-NP	NN	B-DNA	37	NMOD	B-DNA
O	O	O	1678	1679	B	B	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	1679	1680	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
O	O	O	1680	1684	like	like	I-NP	JJ	I-DNA	40	NMOD	I-DNA
T32	B-Entity	B-Entity	1685	1690	sites	site	I-NP	NNS	I-DNA	41	SUB	I-DNA
O	O	O	1691	1694	are	be	B-VP	VBP	O	4	SBAR	O
O	O	O	1695	1704	terminals	terminal	B-NP	NNS	O	41	PRD	O
O	O	O	1705	1707	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	1708	1713	FK506	FK506	B-NP	NN	O	47	NMOD	O
O	O	O	1713	1714	-	-	B-NP	HYPH	O	47	NMOD	O
O	O	O	1714	1723	sensitive	sensitive	I-NP	JJ	O	47	NMOD	O
O	O	O	1724	1731	pathway	pathway	I-NP	NN	O	43	PMOD	O
O	O	O	1732	1741	involving	involve	B-VP	VBG	O	47	NMOD	O
O	O	O	1742	1745	Ca2	Ca2	B-NP	NN	B-protein	51	NMOD	B-protein
O	O	O	1745	1746	+	+	I-NP	SYM	O	51	NMOD	O
O	O	O	1747	1759	mobilization	mobilization	I-NP	NN	O	48	OBJ	O
O	O	O	1759	1760	.	.	O	.	O	3	P	O
